National Comprehensive Cancer Network

Educational Events & Programs

NCCN Academy for Excellence & Leadership in Oncology™

School of Pharmaceutical & Biotech Business

October 14, 2009 – October 15, 2009

Space is limited – Enroll Now!

Program Location
Chicago Marriott Downtown Magnificent Mile
540 North Michigan Avenue
Chicago, IL 60611

Program Overview
Pharmaceutical and biotechnology professionals are given the rare opportunity to view the oncology space, its future and its current operational issues from the provider and payer perspective. Participants will improve their working knowledge of key business, policy, coverage, reimbursement, informational, and operational issues in oncology and will gather valuable insights material to developing effective strategies for navigating the various constituencies in cancer care. Through this interactive program, pharma and biotech professionals will learn from key stakeholders what they view to be the most pressing issues in oncology today and how to apply this knowledge to create mutually-successful working relationships.

Professionals from marketing, sales, medical affairs, clinical research, policy and government affairs, and other business areas all will be better able to serve their customers with improved knowledge of real-world oncology issues after completion of this program.

Target Audience
Experienced professionals from marketing, sales, medical affairs, clinical research, policy and government affairs, and other business areas within the pharmaceutical and biotech industries.

Program Agenda – Wednesday, October 14, 2009

Registration and Breakfast
8:00 – 8:30 AM

Welcome
8:30 – 8:45 AM
William T. McGivney, PhD
National Comprehensive Cancer Network  
           
Module I: The Clinical Side of Oncology
8:50 – 10:05 AM
Michael K. Wong, MD, PhD      
Roswell Park Cancer Institute

Break
10:10 – 10:25 AM

Module II: The Business Side of Oncology
10:25 – 11:40 AM
Patricia J. Goldsmith
National Comprehensive Cancer Network

Lunch
11:45 AM – 12:45 PM

Module III: Personalized Medicine and Your Product: A Panel Discussion
12:45 – 2:15 PM
James D. Cross, MD
Aetna Inc.

Douglas Martin, MD
Leerink Swann Strategic Advisors

James M. Pluda, MD
Merck & Co, Inc.

William T. McGivney, PhD
National Comprehensive Cancer Network 

Michael K. Wong, MD, PhD      
Roswell Park Cancer Institute

Break
2:20 – 2:35 PM

Module IV: Use and Impact of Information Products on Decision Makers in Cancer Care: A Panel Discussion
2:35 –3:50 PM
Jeffrey Allen, PharmD
Humana, Inc.

James D. Cross, MD
Aetna Inc. 

Stephen B. Edge, MD
Roswell Park Cancer Institute

Kristina M. Gregory, RN, MSN, OCN
National Comprehensive Cancer Network  

William T. McGivney, PhD
National Comprehensive Cancer Network

Closing Remarks     
3:55 – 4:00 PM
William T. McGivney, PhD
National Comprehensive Cancer Network

Networking/Reception
4:00 – 5:00 PM

Program Agenda – Thursday, October 15, 2009

                       
Registration and Breakfast
8:00 – 8:30 AM

Module V: Working Effectively with Key Decision-Makers in the U.S. Cancer Care Delivery System
8:30 – 9:45 AM
Al B. Benson III, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

C. Lyn Fitzgerald, MJ
National Comprehensive Cancer Network 

William T. McGivney, PhD
National Comprehensive Cancer Network

Randall C. Mastrangelo
RM Consulting

Lee N. Newcomer, MD, MHA
United Healthcare

Stephanie F. Williams, MD
US Oncology, Inc.

Break
9:50 – 10:05 AM                      

Module VI: Real World Trends Impacting Cancer Care – Cost, Reimbursement, and Policy
10:05 – 11:20 AM
Peter B. Bach, MD, MAPP
Memorial Sloan-Kettering Cancer Center
Former Senior Adviser to the Administrator on Healthcare Quality and Cancer Policy with the Centers for Medicare and Medicaid Services

James D. Cross, MD
Aetna Inc. 

William T. McGivney, PhD
National Comprehensive Cancer Network

Randall C. Mastrangelo
RM Consulting

Lee N. Newcomer, MD, MHA
United Healthcare

Lunch
11:25 AM – 12:25 PM

Module VII:
Pharmacy Budgeting, P&T, and Information Systems: Institutional Decision-Making in the Academic and Community Settings
12:25 – 1:40 PM
Nicky J. Dozier, PharmD
US Oncology, Inc.

Philip E. Johnson, MS, RPh, FASHP
H. Lee Moffitt Cancer Center & Research Institute

Module VIII:
NCCN Compendium and Guidelines Panels, Process, and Users
1:45 – 2:30 PM
Kristina M. Gregory, RN, MSN, OCN
National Comprehensive Cancer Network  

William T. McGivney, PhD
National Comprehensive Cancer Network  

Interactive Summary: Application of NCCN Academy Concepts
2:35 – 2:50 PM
William T. McGivney, PhD
National Comprehensive Cancer Network  

Curriculum and faculty are subject to change.

Tuition

• $2,495 – regular rate
• $2,395 – early bird discount
• $2,295 – early bird discount for NCCN Corporate Council Members
• $2,150 – per attendee for companies sending 10 or more attendees per meeting

Early bird discounts expire on September 18, 2009.

Tuition includes breakfast and lunch on both days. All participants are encouraged to attend the networking reception from 4:00 – 5:00 PM on Wednesday, October 14, 2009.

Recommended attire for the NCCN Academy is business casual. Program handouts will be provided for reference and note-taking.

Registration Information

Enroll now to secure a place in the NCCN Academy for Excellence & Leadership in Oncology™ School of Pharmaceutical & Biotech Business.

Download the Registration Form.

Cancellation policy for registration
If you register for the conference and then cannot attend, a substitute attendee may be sent in your place. A $50 administration fee will be charged for each substitution. A $50 administration fee will be charged for cancellations received through September 18, 2009. After September 18, the registration fee is not refundable.

Hotel Information
NCCN has reserved a limited number of sleeping rooms for the evenings of 10/13 and 10/14 at the rate of $249, plus taxes (15.4%) per night for this event at the Chicago Marriott Downtown Magnificent Mile. Please call 312.836.0100 to make your reservation by Friday, October 2, 2009 indicating that you are with the National Comprehensive Cancer Network (NCCN) group.